http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b107289fb2e5f4503505714ca3cc77af
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Rolfo Christian Rolfo |
| name | Christian Rolfo |
| given-name | Christian |
| organization-name | Phase I - Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA) and Center for Oncological Research (CORE) Antwerp University, Wilrijkstraat 10, 2650, Edegem, Antwerp, Belgium 22Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Phase I - Early Clinical Trials Unit, Antwerp University Hospital, Antwerp, Edegem 2650, Belgium Luis E. Raez and Mark Block, Memorial Healthcare System, Hollywood; Edgardo S. Santos, Boca Raton Regional Hospital, Boca Raton, FL; Amanda Nogueira, David Arias Ron, and Christian Rolfo, Antwerp University Hospital, Edegem, Belgium; Ricardo Sales Dos Santos, Juliana Franceschini, and Nise Yamaguchi, Hospital Israelita Albert Einstein, São Paulo, Brazil. Antwerp University Hospital, Centre of Oncologic Research (CORE) Antwerp University, Edegem, Belgium; Multidisciplinary Oncologic Centre Antwerp (MOCA), Edegem, Belgium; Phase I - Early Clinical Trials Unit, Oncology Department, University Hospital Antwerp UZA, Edegem, Belgium 1Center for Oncological Research, University of Antwerp, Antwerp, Belgium.; 4Phase I - Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital, Antwerp, Belgium. Center for Oncological Research University of Antwerp Antwerp Belgium; Phase I‐Early Clinical Trials Unit, Oncology Department Antwerp University Hospital Antwerp Belgium Phase I‐Early Clinical Trials Unit Oncology Department Antwerp University Hospital Edegem Belgium Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai Medical System & Icahn School of Medicine at Mount Sinai, New York, NY, USA Center for Thoracic Oncology Tisch Cancer Institute Mount Sinai Medical System & Icahn School of Medicine Mount Sinai, New York New York USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland School of Medicine Baltimore Maryland USA Department of Oncology, Antwerp University Hospital, Antwerp, 2650, Edegem, Belgium; Phase 1-Early Clinical Trials Unit, Antwerp University Hospital, Antwerp, 2650 Edegem, Belgium Thoracic Medical Oncology and Early Clinical Trials Unit, University of Maryland, Baltimore, MD, USA University Hospital, Antwerp, Belgium Center for Thoracic Oncology, Tisch Cancer Center, Mount Sinai Hospital System, New York, NY, USA; Icahn School of Medicine, Mount Sinai, New York, NY, USA Department of Oncology, University Hospital of Antwerp, Edegem, Belgium 1 Phase I-Early Clinical Trials Unit, Oncology Department and Multidisciplinary Oncology Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium ; 2 Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy ; 3 Molecular Pathology Unit, Pathology Department, Antwerp University Hospital, Edegem, Belgium ; 4 Memorial Cancer Institute, Memorial Health Care System, Florida International University, Miami, FL, USA ; 5 Thoracic Oncology Unit, Integrated Cancer Centre, AZ Maria Middelares, Gent, Belgium ; 6 Lung Cancer Unit, Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain ; 7 Thoracic Oncology, Multidisciplinary Oncology Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium ; 8 Thoracic Surgery Department, Antwerp University Hospital, Edegem, Belgium. Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, United States. University of Maryland Medical Center Greenebaum Comprehensive Cancer Center, Baltimore, MD; University Hospital Antwerp, Antwerp University, Antwerp, Belgium Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York Department of Medical Oncology, Antwerp University Hospital, Antwerp, Belgium Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai Medical System & Icahn School of Medicine, Mount Sinai, New York, NY, USA. christian.rolfo@mssm.edu. Center for Oncological Research Antwerp, Center for Oncological Research Antwerp (CORE), Antwerp University, Wilrijk, Belgium; Department of Oncology, Antwerp University Hospital, Edegem, Belgium; Phase 1-Early Clinical Trials Unit, Antwerp University Hospital, Edegem, Belgium Phase I Early Clinical Trials Unit, Department of Oncology Universitair Ziekenhuis Antwerpen Edegem Belgium Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital and Center for Oncological Research (CORE), Antwerp University, Edegem, Belgium. Phase I, Early Clinical Trials Unit, Antwerp University Hospital, Edegem, Belgium; Centre of Oncological Research (CORE), Antwerp University, Edegem, Belgium University of Maryland Medical Center, Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA. Christian.rolfo@umm.edu. Head of Phase I - Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital and Antwerp University, Wilrijkstraat 10, 2650 Edegem, Belgium Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital and Center for Oncological Research (CORE), Antwerp University, Edegem, Belgium Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, New York, NY 11776, USA Phase I-Early Clinical Trials Unit, Oncology Department, University Hospital Antwerp, Edegem, Belgium. christian.rolfo@uza.be. Center or Oncological Research (CORE), Antwerp University, Antwerp, Belgium. christian.rolfo@uza.be. Phase I – Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital & Center for Oncological Research (CORE) Antwerp University, Edegem, Belgium Center for Thoracic Oncology, Tisch Cancer Institute at Icahn School of Medicine, Mount Sinai, New York, NY, USA. Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA) and Center for Oncological Research (CORE) Antwerp University, Wilrijkstraat, Edegem, Antwerp, Belgium Thoracic Medical Oncology and Early Clinical Trials, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1079, New York, NY 10029-6574, USA Oncology Department, University Hospital Antwerp, Wilrijkstraat 10, 2650 Edegem, Belgium Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai Medical System & Icahn School of Medicine, New York, NY, USA Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University HospitalBelgium. 8Oncology Department, Antwerp University Hospital (UZA) and Center for Oncological Research (CORE) Antwerp University, Antwerp, Belgium. 2University Hospital Antwerp, Edegem, Belgium. Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA) and Center for Oncological Research (CORE) Antwerp University, Edegem, Antwerp, Belgium Phase I - Early Clinical Trials Unit Oncology Department and Center of Oncological Research (CORE), University Hospital Antwerp & Antwerp University, Belgium Phase I- Early Clinical Trials Unit, Antwerp University Hospital, Edegem, Belgium Phase I-Early Clinical Trials Unit, Oncology Department and Multidisciplinary Oncology Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium Department of Oncology Antwerp University Hospital Edegem Belgium; Phase 1‐Early Clinical Trials Unit Antwerp University Hospital Edegem Belgium Thoracic Oncology Unit, Marlene and Stewart Comprehensive Cancer Center University of Maryland Baltimore Maryland USA Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital, Antwerp, Belgium; Center for Oncological Research (CORE), Antwerp University, Antwerp, Belgium Michael J. Pishvaian and Stephen V. Liu, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Ignacio Garrido-Laguna, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Pratik S. Multani and Edna Chow-Maneval, Ignyta, San Diego, CA; and Christian Rolfo, Antwerp University Hospital and Center of Oncological Research, Antwerp University, Antwerp, Belgium Department of Medical Oncology, Antwerp University Hospital, Antwerp, Belgium; Phase-1 Early Clinical Trials Unit, Antwerp University Hospital, Antwerp, Belgium Alessandro Leonetti, MD, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands, and University Hospital of Parma, Parma, Italy; Marcello Tiseo, MD, PhD, University Hospital of Parma and University of Parma, Parma, Italy; Christian Rolfo, MD, PhD, MBA, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD; Nele Van Der Steen, PhD, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands, and Center... Phase I- Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital, “Centre for Oncological Research (CORE)”, Edegem, Belgium Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA Thoracic Oncology Department and Early Phase Clinical Trials Section, School of Medicine, Maryland University, Maryland, USA. Electronic address: christian.rolfo@umm.edu. Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA Phase I- Early Clinical Trials Unit, Oncology Department and Multidisciplinary Oncology Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium Center for Thoracic Oncology, Tisch Cáncer Center, Mount Sinai Hospital System & Icahn School of Medicine, Mount Sinai, New York, NY, United States. Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA. Thoracic Oncology Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA. christian.rolfo@umm.edu. Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA. christian.rolfo@umm.edu. Marlene and Stewart Comprehensive Cancer Center, Experimental Therapeutics Program, School of Medicine, University of Maryland, Baltimore, MD University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore; International Society of Liquid Biopsy, Granada, Spain Thoracic Oncology Unit, Marlene and Stewart Comprehensive Cancer Center University of Maryland Baltimore MD USA |
Incoming Links
Total number of triples: 310.